Analysis of Artificial Implants market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
The global artificial implants market is projected to evolve at a CAGR of 5.6% from 2022 to 2032. At present, the market is valued at US$ 150 billion and is predicted to reach US$ 260 billion by the end of 2032.
Demand for cardiac implants is anticipated to propel at a CAGR of 7% through 2032 due to the increased risk of cardiovascular diseases caused by dietary and lifestyle changes.
Artificial implants are placed into the body to take the place of a lost limb or a damaged organ. Depending on their intended usage, artificial implants can be created from metal, plastic, ceramic, and others. They typically last longer than many other medical devices since they are not in contact with bodily fluids as frequently as those used in medical operations.
Health implants are manufactured of immune system-inert materials; hence, they don't trigger allergic reactions. They are used to treat urgent situations where rapid organ loss is difficult to manage and requires immediate replacement with implants, in addition to chronic, long-term illnesses. Artificial implants are used to simulate bone and joint function in orthopedics and dentistry.
More lives are being saved than ever thanks to creative solutions to medical issues that the average person in modern society faces. The stability of the implant after initial insertion depends on the body's capacity to develop and maintain healthy bone structure around the implant, a process known as osseointegration.
A prosthetics implant is an artificial device that replaces a missing body component. This missing body part can be caused by trauma, illness, or a birth defect. A type of tissue used for organ transplantation is biomedical tissue. To restore a specific function or a group of related functions to aid the patient in returning to as normal a life as possible, an artificial organ is a man-made device that is implanted or merged into a human to replace a natural organ.
In contrast to transferring organs or tissue, artificial implants are built artificially or are referred to as 'manmade'. Others are bioactive, while other implants have electronic components such as pacemakers. Healthcare is a traditional industry application for artificial implants.
The main causes of organ failure are acute diseases, drug addiction, severe trauma, and blood loss. Bad lifestyle choices such as smoking, drinking too much alcohol, eating poorly, and not exercising have a significant impact on organ function. Additionally, it is forecasted that improvements in healthcare facilities and the accessibility of cutting-edge artificial support systems will drive demand for artificial implants.
The use of artificial implants is mostly driven by the growing elderly population worldwide. An increasing number of patients over 65 are requesting and getting organ transplants. As they are more prone to post-transplant malignancies, the elderly population boosts the sales of artificial devices.
The artificial implants market is expected to be driven by the population's longer life expectancy. The growth of the artificial implants industry is attributed to rising healthcare spending, which will increase the demand for progressive healthcare among the general public and expand intervention with advanced treatments.
Artificial Implants Market Size (2022)
US$ 150 Billion
Projected Market Value (2032)
US$ 260 Billion
Global Market Growth Rate (2022-2032)
Market Share of Cardiac Implants
Key Companies Profiled
Don't Need a Global Report?
Save 40% on Country & Region specific reports
“Growing Awareness of Artificial Implants among General Population”
A high rate of technological advancements in the implant business would accelerate the use of these treatments. The increasing awareness of artificial implants among people is enhancing market growth potential for medical implants.
Since 3D bioprinting is utilized to create artificial implants, it has become clear that advances in this area are essential for organ transplantation. Since 3D bioprinting reduces the possibility of organ rejection, it is gaining popularity. The global trends for artificial devices are also about to change as a result of artificial intelligence.
For many years, hydroxylapatite (HA) has been employed in clinical settings. Due to its chemical composition closely resembling bone material, it has good biocompatibility with bone contact. For bone repair and bone regeneration, hydroxyapatite of biologic is currently used in the form of granules, blocks, and scaffolds, either alone or in a composite with polymers or other ceramics, or as a coating on dental or orthopedic implants.
“Rising Demand for Aesthetic Operations”
Increase in the number of people with impairments, the growing prevalence of aesthetic operations, high disposable income, recent innovations in medical implants, and the accessibility of advanced healthcare systems are a few additional factors driving the global artificial implants market.
Globally, spending on healthcare is rising, with most governments now dedicating 10% of their GDP to this industry. The general public becomes more demanding of modern healthcare as a result, which increases intervention with creative solutions. Because of this pattern, artificial implants are becoming more accepted, and this trend is expected to continue.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
“High Risks Associated with Medical Implants & Strict Regulatory Standards”
Surgical hazards during implantation or removal, infection, and implant failure are among the risks associated with medical implants. The materials used in implant surgery can cause allergies in some patients.
The market is anticipated to be constrained during the projected period by the high cost of artificial implants and strict regulatory standards.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
“New Entrants Can Focus on R&D to Create Advanced Products & Solutions”
Start-ups are investing in R&D to create unique products and solutions. Some orthopedic disorders are challenging to treat because of the relatively smaller or more intricate bones and other components.
One instance is thumb base arthritis, which makes it difficult for sufferers to perform daily chores such as using a phone and creates constant pain. Emerging market players are developing implants that function similarly to small joints to meet the needs of orthopedic patients.
“High Demand for Cosmetic Dental Treatments in North America”
North America accounts for the highest share of the artificial implants market due to the advanced healthcare system, quick uptake of sensory and neurological implants, and high prevalence of chronic diseases.
The presence of leading medical implant companies, the rising prevalence of conditions such as arthritis, the increasing demand for cosmetic dental treatments, and favorable insurance policies are all factors driving market value in the region.
“Increase in Transplant Surgeries in the U.S.”
High demand for dental implants among the ageing population, growing sales of facial implants, and widespread use of hearing implant devices are propelling market expansion in the United States.
The surge in medical implant launches, the increase in transplant surgeries, and the demand for artificial organs due to the rising rate of organ failure are all factors that are stimulating market revenue.
“Rapid Utilization of Advanced Implantation Techniques”
The artificial implants market in China is predicted to develop at a CAGR of 10% from 2022 to 2032. Market growth is driven by factors such as an ageing population, increased awareness of smart implants, high demand for artificial implants for breasts, and rapid utilization of advanced implantation techniques.
The market is expanding in China as a result of the rising use of knee replacement implants, developing medical tourism, an increase in the prevalence of impairments, and technological advancements leading to better applications.
“Growing Usage of Cardiac Implants for Management of Cardiac Arrhythmias”
By product type, the artificial implants market is divided into cardiac implants, spinal implants, knee implants, hip implants, dental implants, and cochlear implants. Cardiac implants account for 50% share of the global market.
The increased prevalence of heart failure is anticipated to lead to more cardiac surgeries, which is fueling demand for cardiac implants. Devices such as pacemakers or artificial hearts are examples of cardiac implants. By giving electrical shocks when necessary to make the heart muscles work harder, they assist the cardiac muscles in better executing their role.
The management of cardiac arrhythmias involves the use of cardiac implants. By administering therapies to treat irregular problems that might otherwise have prevented the organ from working properly, these devices aid in the treatment of cardiac patients.
“Metallic Implants More Preferred for Total Joint Replacement”
The artificial implants market is segmented into metallic, ceramic, polymers & natural, and others based on biomaterial.
Sales of metallic implants are expected to rise at a significant CAGR throughout the forecast period. The most common biomaterials used in joint replacement are metallic implants, which are becoming more prominent. Orthopedic applications use different types of metallic implants.
These metallic materials have many properties, such as high tensile strength, high impact resistance, rigidity, oxidation resistance, and biocompatibility that make them an excellent substitute for total joint replacement.
Due to their excellent mechanical qualities, metallic implants are the most common orthopedic implants and are frequently used for joint replacement, bone trauma restoration, and other procedures.
Leading companies are working to boost their revenue share in the market by developing novel products. Major market participants can increase their geographic reach and their current product portfolio through mergers and acquisitions.
For instance :
- Premium Report Details -
- Let's Connect -
- Quick Contact -
- Get Started -
Get insights that lead to new growth opportunitiesBuy Now
Get A Special pricing for start-ups and universitiesEnquiry Before Buying
- Humble, Yet Honored -
- Research Methodology -
An Adaptive Approach to Modern-day Research NeedsGet Methodology
- Related Reports -
At present, the global artificial implants market is valued at US$ 150 billion.
Sales of artificial implants are estimated to reach US$ 260 billion by 2032.
Increasing prevalence of chronic diseases and growing awareness about artificial implants are supporting market growth.
Demand for artificial implants is predicted to amplify at a CAGR of 5.6% from 2022 to 2032.
Exactech Inc., Smith & Nephew Plc, and Sonova Holding AG are key manufacturers of artificial implants.
Need An Exclusive Report For Your Unique Requirement?